Additionally, our study provided evidence that biomarkers of inflammation hs-CRP, IL-1β, neopterin, and adiponectin may be helpful in the thorough evaluation and ongoing care of patients with COPD in primary care. This evidence concerns the gene IL1B and chronic obstructive pulmonary disease.